
News

- Using in-vitro models of a specific type of brain cell, scientists show that neurons are capable of changing from one type to another.
- Three UC Santa Cruz faculty members have been named new fellows of the American Association for the Advancement of Science. AAAS awarded the lifetime honor to professors David Deamer, Theodore Holman, and Raphael Kudela on March […]
- Using CRISPR-based engineering methods to prompt stem cells to organize into embryo-like structures, scientists at UC Santa Cruz were able to create “programmable” cellular models of embryos without ever experimenting with any actual embryos.
- The UC Santa Cruz Colligan Clinical Diagnostic Laboratory has received its CLIA certificate of registration from the California Department of Public Health, which clears the way for it to begin accepting patient samples.
- Newest Genome Browser features highlight the power of generative AI and machine learning for biologyThe UCSC Genome Browser has added two new datasets that leverage the power of generative AI and machine learning to interpret information about genetic variants and more rapidly assess which ones might be harmful to human […]
- Not only is the banana slug the endearing mascot for UC Santa Cruz — making the project fitting for campus researchers — but the slugs’ unique slime was a particularly challenging undertaking for UCSC’s experts in […]
- UC Santa Cruz has announced the Innovation Catalyst Grant proof-of-concept program awardees, showcasing the campus’s commitment to fostering transformative research with significant societal benefits.
- A new study shows that long-read sequencing has the potential to improve the rate of diagnosis while reducing the time to diagnosis from years to days — in a single test and at a much lower […]
- UC Santa Cruz Professor Emeritus of Biomolecular Engineering Mark Akeson has been named a Fellow of the National Academy of Inventors.
- Two UC Santa Cruz faculty members, Richard (Ed) Green and Chris Benner, have been selected as awardees for the eighth annual Santa Cruz Works Titans Awards
- Several current and former UC Santa Cruz faculty and staff have joined with leading experts in the field of conservation genomics to launch Wise Ancestors, a non-profit centering Indigenous Peoples and Local Communities as co-creators of […]
- In a notable recognition of scholarly achievement, 24 scientists and engineers from UC Santa Cruz have earned a spot on the 2024 Highly Cited Researchers list, recently unveiled by Clarivate.
- The 2024 UC Santa Cruz iGEM team won a silver medal at the international Jamboree for a project focused on addressing the high cost of infant formula through a foundational synthetic biology approach.
- In what could one day become a new treatment for epilepsy, researchers at UC San Francisco, UC Santa Cruz and UC Berkeley have used pulses of light to prevent seizure-like activity in neurons.
- Assistant Professor of Biomolecular Engineering Andy Yeh is designing completely artificial proteins that produce bioluminescence to serve as a non-invasive method for bioimaging, diagnostics, drug discovery, and more.
- The CDC has awarded Corbett-Detig and his team at the UCSC Genomics Institute a two-year, $2.52 million contract to continue their work tracking the COVID-19 virus’s evolution and expand their software tools to track other pathogens.
- The Genomics Institute has awarded grants of up to $50,000 to six multidisciplinary research projects in the inaugural year of its seed funding program
- Sixteen outstanding UC Santa Cruz graduate students in science and engineering fields earned scholarships worth a total of $180,000 from the Achievement Rewards for College Scientists (ARCS) Foundation for the 2024-25 academic year.
- A new award from the California Institute for Regenerative Medicine will support a team of UC Santa Cruz researchers in exploring the genetic underpinnings of autism spectrum disorder.
- Ph.D student Asia Anderson focuses on the development of brain machine interfaces to model and study the development of the human brain, specifically those with neurodegenerative disorders.